Reduction in Skin Cancer Diagnoses in the UK during COVID-19 Pandemic

Skin Cancer

Clin Exp Dermatol. 2020 Aug 5. doi: 10.1111/ced.14411. Online ahead of print.


The UK healthcare system has been profoundly affected by the COVID-19 Pandemic, including skin cancer departments. Despite service capacity and a worldwide increase in incidence, anecdotal reports suggest a decline in skin cancer diagnoses following COVID-19. To determine if there is a decrease in skin cancer diagnosis in the UK in the COVID-19 era, we analysed data from the Northern Cancer Network from March 23rd 2020 to June 23rd 2020 and compared it to the same period last year. In the COVID Period there was a decrease in skin cancer diagnoses of 68.61% from 3619 to 1136 (p<0.0028). Surprisingly, skin cancer waiting times were also reduced in the COVID Period compared to Before COVID Period (median 8 days and 12 days respectively; p<0.0001). Collectively these data highlight a statistically significant reduction in both skin cancer diagnoses and waiting times during the COVID Period.